Skip to content
Menu

Denali Therapeutics Inc. DNLI

Full chart Compare
Set alert

Price alert · DNLI

All alert types
18.45 USD +0.25 (+1.37%)

Regular-session close

18.45 0.00 0.00%

After hours · Nov 20, 4:52 PM ET

17.92 Day range 18.85
16.02 52-week range 27.21
YTD
+11.75%
1 year
+7.52%

Revenue & Expenses

Revenue Profit Costs
Other Income$51.51MGross Profit$330.53MNet Loss$145.22MExpenses$527.26MSelling, General & Admin$103.35MResearch & Development$423.88MRevenue$330.53M

Latest period ending Dec 31, 2025 · select a line to chart its full history

DNLI annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-555.34M-487.34M-196.70M-340.74M-295.75M
-512.54M-422.77M-145.22M-325.99M-290.58M
-2.97-2.57-1.06-2.60-2.39
DNLI annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
205.33M174.96M127.11M218.04M293.48M
1.14B1.37B1.15B1.46B1.40B
131.09M144.50M122.96M417.81M441.87M
32.74M42.29M44.98M53.03M58.55M
1.01B1.23B1.03B1.04B962.29M
DNLI annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-412.60M-347.69M-357.99M-244.72M-211.39M
255.28M-88.76M249.31M-141.39M-21.63M
189.22M484.30M17.82M310.67M19.35M
-9.50M-15.91M-12.94M-17.83M-8.50M
31.90M47.85M-90.86M-75.43M-213.67M